Duncan Emerton - Senior Director of Syndicated Insights and Analysis and Sorcha Cassidy - Senior analyst - discuss some of the key findings from a forthcoming Payer Insight: RA report
We interviewed 12 US and EU payers with expertise in formulary management and drug reimbursement to get the short- to medium-term outlook for the RA market.
You’ll learn how payers are making key reimbursement and market access decisions, what biosimilar manufacturers need to do to win over stakeholders, how originators are defending their market share, and whether pipeline therapies have any hope of breaking into this fiercely competitive space.
Click here for more information
To read more Analyst Notes articles, click here.